Infectious Disease Focused Zalgen Labs Opens New HQ in Frederick, Eyes Clinical Trial for Lassa Fever Therapeutic · BioBuzz
Zalgen Labs is beginning 2022 with new space in Frederick, Maryland and plans to file an IND for its developmental Lassa fever therapy, Arevirumab-3.
Source: biobuzz.io